BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9436479)

  • 1. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
    Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E
    Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
    Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ
    J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC).
    Niccoli-Sire P; Murat A; Baudin E; Henry JF; Proye C; Bigorgne JC; Bstandig B; Modigliani E; Morange S; Schlumberger M; Conte-Devolx B
    Eur J Endocrinol; 1999 Nov; 141(5):468-74. PubMed ID: 10576762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
    Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
    Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma.
    Erdoğan MF; Güllü S; Başkal N; Uysal AR; Kamel N; Erdoğan G
    J Clin Endocrinol Metab; 1997 Mar; 82(3):897-9. PubMed ID: 9062503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
    Grauer A; Raue F; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
    Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
    Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
    Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
    Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.
    Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential absence of prognostic implications of severe preoperative hypercalcitoninemia in medullary thyroid carcinoma.
    Zangeneh F; Gharib H; Goellner JR; Kao PC
    Endocr Pract; 2003; 9(4):284-9. PubMed ID: 14561572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of genetic screening in families with hereditary medullary thyroid carcinoma.
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():108-10. PubMed ID: 8981015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.